|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2022
12 months to Dec 31, 2022
|
FY2021
9 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| General and administrative expense | ||||
| Administrative expense-related party | ||||
| Net revenue | ||||
| Net revenue | ||||
| Product | ||||
| Service | ||||
| Total net revenue | ||||
| Cost of revenue: | ||||
| Product | ||||
| Service | ||||
| Total cost of revenue | ||||
| Gross profit | ||||
| Operating expenses: | ||||
| Research and development | ||||
| Selling, general and administrative | ||||
| Impairment of long-lived assets | ||||
| Loss from operations | ||||
| Interest expense | ||||
| Change in fair value of earnout liability | ||||
| Change in fair value of warrants | ||||
| Interest earned on marketable securities held in trust account | ||||
| Day one loss in PIPE Derivative Liability | ||||
| Gain from change in fair value of PIPE Derivative Liability | ||||
| Total other income | ||||
| Change in fair value of PIPE make-whole liability | ||||
| Change in fair value of SAFEs | ||||
| Private placement costs | ||||
| Financing costs expensed | ||||
| Other non-operating losses, net | ||||
| Loss before income taxes | ||||
| Provision (benefit) for income taxes | ||||
| Net loss and comprehensive loss | ||||
| Deemed dividend from warrant price adjustment | ||||
| Net loss available to common stockholders | ||||
| Total net loss available to common stockholders | ||||
| Basic | ||||
| Ordinary shares subject to redemption | ||||
| Non-redeemable ordinary share | ||||
| Total basic | ||||
| Diluted | ||||
| Ordinary shares subject to redemption | ||||
| Non-redeemable ordinary share | ||||
| Total diluted | ||||
Loading...